ERAP2 and cancer: Aberrant isoform usage and splicing have previously been associated with the human antiviral response, cancer, and neurodegenerative diseases64–66; moreover, a recent study found that SARS-CoV-2 infection alters isoform usage of the ERAP2 gene67.